Zacks Research Issues Pessimistic Estimate for CLB Earnings

Core Laboratories Inc. (NYSE:CLB) – Stock analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for shares of Core Laboratories in a research report issued on Wednesday, December 4th. Zacks Research analyst T. Saha now forecasts that the oil and gas company will post earnings of $1.00 per share for the year, down from their previous forecast of $1.07. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.25 EPS and Q3 2026 earnings at $0.30 EPS.

Several other analysts have also issued reports on the stock. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup lowered their price objective on Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $17.00.

Core Laboratories Price Performance

Shares of NYSE CLB opened at $19.86 on Thursday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48. The firm has a fifty day moving average of $19.59 and a 200 day moving average of $19.61. The firm has a market cap of $932.43 million, a PE ratio of 31.03, a PEG ratio of 1.39 and a beta of 2.35. Core Laboratories has a one year low of $13.82 and a one year high of $25.13.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. The business had revenue of $134.40 million during the quarter, compared to analysts’ expectations of $134.16 million. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The business’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 earnings per share.

Hedge Funds Weigh In On Core Laboratories

Hedge funds and other institutional investors have recently modified their holdings of the business. Tidal Investments LLC grew its stake in Core Laboratories by 1.7% during the 3rd quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company’s stock valued at $813,000 after acquiring an additional 716 shares in the last quarter. Barclays PLC boosted its holdings in shares of Core Laboratories by 288.2% during the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after purchasing an additional 62,042 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Core Laboratories by 0.7% in the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock valued at $19,521,000 after purchasing an additional 7,721 shares in the last quarter. Disciplined Growth Investors Inc. MN increased its holdings in shares of Core Laboratories by 26.7% in the third quarter. Disciplined Growth Investors Inc. MN now owns 5,653,591 shares of the oil and gas company’s stock valued at $104,761,000 after purchasing an additional 1,192,871 shares during the last quarter. Finally, Jane Street Group LLC lifted its position in Core Laboratories by 53.8% during the third quarter. Jane Street Group LLC now owns 71,989 shares of the oil and gas company’s stock worth $1,334,000 after buying an additional 25,189 shares in the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Monday, November 4th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.20%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s payout ratio is 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.